Skip to main content
. 2019 Mar 3;38(2):153–163. doi: 10.2478/jomb-2018-0023

Table III.

Comparison of clinical and biochemical characteristics between different genotypes of FTO gene polymorphism rs8050136: A>C in healthy subjects.

FTO rs8050136 A>C
AA (n=79) AC (n=140) CC (n=87) p-value AA/AC p-value AA/CC p-value AC/CC
Fasting glucose (mmol/L) 5.02 ± 0.138 5.18 ± 0.055 5.15 ± 0.117 0.996 0.561 0.502
HbA1c (%) 9.37 ± 3.811 5.47 ± 0.048 5.39 ± 0.062 0.119 0.016 0.246
Fasting insulin (mU/L) 11.27 ± 2.227 11.17 ± 1.105 10.443 ± 0.801 0.674 0.486 0.751
+ HOMA-IR 2.212 ± 0.206 2.629 ± 0.282 2.49 ± 0.217 0.744 0.618 0.842
BMI (kg/m2) 29.41 ± 2.661 26.91 ± 0.589 27.02 ± 0.805 0.133 0.221 0.880
Waist circumference (cm) 98.55 ± 1.638 94.07 ± 1.012 92.78 ± 2.008 0.163 0.076 0.630
Hip circumference (cm) 109.25 ± 1.498 106.27 ± 0.884 106.55 ± 2.574 0.414 0.635 0.194
Systolic BP (mm Hg) 123.05 ± 2.181 120.43 ± 1.803 126.75 ± 2.107 0.375 0.175 0.108
Diastolic BP (mm Hg) 82.65 ± 1.128 79.13 ± 0.665 80.43 ± 1.112 0.020 0.362 0.179
Triglycerides (mmol/L) 1.75 ± 0.137 1.66 ± 0.082 1.64 ± 0.112 0.781 0.835 0.600
Total cholesterol (mmol/L) 5.37 ± 0.167 5.44 ± 0.106 5.36 ± 0.157 0.521 0.679 0.850
HDL cholesterol (mmol/L) 1.21 ± 0.054 1.34 ± 0.040 1.27 ± 0.051 0.040 0.169 0.585
LDL-cholesterol (mmol/L) 3.51 ± 0.119 3.45 ± 0.088 3.48 ± 0.115 0.426 0.414 0.914
VLDL-cholesterol (mmol/L) 0.735 ± 0.118 0.822 ± 0.089 0.687 ± 0.066 0.152 0.576 0.365
hsCRP (mg/L) 3.72 ± 0.433 3.39 ± 0.228 3.66 ± 0.428 0.896 0.964 0.933
Fibrinogen (g/L) 5.30 ± 1.584 3.81 ± 0.601 3.11 ± 0.083 0.035 0.013 0.439
Leukocytes (109/L) 6.77 ± 0.192 6.19 ± 0.170 6.44 ± 0.235 0.006 0.133 0.330
Sedimentation (mm/h) 12.65 ± 2.893 11.13 ± 1.320 10.06 ± 2.518 0.820 0.801 0.937

Values represent mean ± standard error mean (SEM), p-values show the significance of the differences of clinical and biochemical characteristics between the stated genotypes of FTO gene polymorphism rs8050136: A>C. All differences were tested using ANCOVA test (adjusted for age, sex and BMI).